Adiponectin Alleviates Intestinal Fibrosis by Enhancing AMP-Activated Protein Kinase Phosphorylation

Translocation of Viable Gut Microbiota to Mesenteric Adipose Drives Formation of Creeping Fat in Humans

(2020) Connie W.Y. Ha et al.   CELL

The Role of Adipose Tissue in the Pathogenesis and Therapeutic Outcomes of Inflammatory Bowel Disease

(2019) Eder et al.   Cells

Primary Human Fibroblasts in Culture Switch to a Myofibroblast-Like Phenotype Independently of TGF Beta

(2019) Ulrike Baranyi et al.   Cells

CD4CD8αα IELs: They Have Something to Say

(2019) Chao Zhou et al.   Frontiers in Immunology

Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases

(2019) Jan Bilski et al.   Biomolecules

Anti-fibrogenic Potential of Mesenchymal Stromal Cells in Treating Fibrosis in Crohn’s Disease

(2018) Lei Lian et al.   DIGESTIVE DISEASES AND SCIENCES

Deletion of delta-like 1 homologue accelerates fibroblast–myofibroblast differentiation and induces myocardial fibrosis

(2018) Patricia Rodriguez et al.   EUROPEAN HEART JOURNAL

Adiponectin administration alleviates DSS-induced colonic inflammation in Caco-2 cells and mice

(2018) Qin Zhao et al.   INFLAMMATION RESEARCH

Inhibition of Fibroblast Activation Protein Restores a Balanced Extracellular Matrix and Reduces Fibrosis in Crohn’s Disease Strictures Ex Vivo

(2018) Marta Truffi et al.   INFLAMMATORY BOWEL DISEASES

Fibrostenotic Phenotype of Myofibroblasts in Crohn’s Disease is Dependent on Tissue Stiffness and Reversed by LOX Inhibition

(2018) Jessica R de Bruyn et al.   Journal of Crohns & Colitis

AMP-activated protein kinase/myocardin-related transcription factor-A signaling regulates fibroblast activation and renal fibrosis

(2018) Yuguo Wang et al.   KIDNEY INTERNATIONAL

Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice with Chronic Intestinal Inflammation

(2018) Kristina Scheibe et al.   GASTROENTEROLOGY

Adipokines and Their Role in Intestinal Inflammation

(2018) Carl Weidinger et al.   Frontiers in Immunology

Treatment of Intestinal Fibrosis in Experimental Inflammatory Bowel Disease by the Pleiotropic Actions of a Local Rho Kinase Inhibitor

(2017) Tom Holvoet et al.   GASTROENTEROLOGY

Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases

(2017) Florian Rieder et al.   GASTROENTEROLOGY

Maternal Adiponectin Controls Milk Composition to Prevent Neonatal Inflammation

(2015) Zixue Jin et al.   ENDOCRINOLOGY

Intestinal Myofibroblast TRPC6 Channel May Contribute to Stenotic Fibrosis in Crohnʼs Disease

(2015) Lin Hai Kurahara et al.   INFLAMMATORY BOWEL DISEASES

Adiponectin in Asthma and Obesity: Protective Agent or Risk Factor for More Severe Disease?

(2015) Renato de Lima Azambuja et al.   LUNG

What We Talk About When We Talk About Fat

(2014) Evan D. Rosen et al.   CELL

Adiponectin Promotes Monocyte-to-Fibroblast Transition in Renal Fibrosis

(2013) J. Yang et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis

(2011) Jeffrey A. Handy et al.   BIOCHEMICAL JOURNAL

Adiponectin protects against doxorubicin-induced cardiomyopathy by anti-apoptotic effects through AMPK up-regulation

(2010) Masanori Konishi et al.   CARDIOVASCULAR RESEARCH

Breakdown of tolerance to the intestinal bacterial flora in inflammatory bowel disease (IBD)

(2010) T. T. MACDONALD   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Is Crohnʼs creeping fat an adipose tissue?

(2010) Isabelle Olivier et al.   INFLAMMATORY BOWEL DISEASES